VEGFA and coronary artery disorder: Numerous studies have demonstrated that VEGF could attenuate endothelial cell injury or endothelial dysfunction to relieve the pathogenesis of patients with CAD (Jin et al., 2015; Longchamp et al., 2018; Liang et al., 2020).